EWM
GILD icon

Elite Wealth Management’s Gilead Sciences GILD Stock Holding History

Elite Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-37
Closed -$1K – 675
2014
Q2 		$1K Buy
+37
New +$2.88K ﹤0.01% 420

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Elite Wealth Management's GILD Position: Q2 2026 in Review

Elite Wealth Management increased its Gilead Sciences (GILD) stake by 46% in Q2 2026, buying an estimated $628K and bringing the position to 15,232 shares worth $1.92M. The position accounts for 0.57% of the portfolio, ranked #25.

Elite Wealth Management first reported a position in GILD in Q1 2014 and has held it in 10 quarters since. The position peaked at $2.19M in Q2 2015. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Elite Wealth Management held 15,232 shares of Gilead Sciences worth $1.92M as of Q2 2026.
  • Elite Wealth Management bought 4,764 Gilead Sciences shares in Q2 2026, an estimated $628K.
  • Gilead Sciences made up 0.57% of Elite Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Elite Wealth Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 10 quarters since.
  • Elite Wealth Management's Gilead Sciences position peaked at $2.19M in Q2 2015.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Elite Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.